Pharmacoeconomic review of medical management of persistent asthma.
about
Effects of the β-agonist, isoprenaline, on the down-regulation, functional responsiveness and trafficking of β2-adrenergic receptors with N-terminal polymorphisms.Timing of emergency department visits for childhood asthma after initial inhaled corticosteroid use.Cost-consequence analysis of multimodal interventions with environmental components for pediatric asthma in the state of MarylandAcute exacerbations of asthma: epidemiology, biology and the exacerbation-prone phenotype.An essential role for mast cells as modulators of neutrophils influx in collagen-induced arthritis in the mouse.
P2860
Pharmacoeconomic review of medical management of persistent asthma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pharmacoeconomic review of medical management of persistent asthma.
@en
Pharmacoeconomic review of medical management of persistent asthma.
@nl
type
label
Pharmacoeconomic review of medical management of persistent asthma.
@en
Pharmacoeconomic review of medical management of persistent asthma.
@nl
prefLabel
Pharmacoeconomic review of medical management of persistent asthma.
@en
Pharmacoeconomic review of medical management of persistent asthma.
@nl
P356
P1476
Pharmacoeconomic review of medical management of persistent asthma.
@en
P2093
Judy W M Cheng
Renée J Goldberg Arnold
P304
P356
10.2500/AAP.2008.29.3105
P577
2008-03-01T00:00:00Z